Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Clinical, Cytogenetic and Molecular Characterization of a 96 MDS and AML Cohort with TP53 Mutation

Blood (2023) 142 (Supplement 1): 6483.

https://doi.org/10.1182/blood-2023-186086

Published: 2023

Journal Articles

Poor Prognosis of SRSF2 Gene Mutations in Patients Treated with Venetoclax-Azacitidine (VEN-AZA) for Newly Diagnosed Acute Myeloid Leukemia. a Multicentric Real-Life Study of 117 Patients

Blood (2023) 142 (Supplement 1): 2848.

https://doi.org/10.1182/blood-2023-180733

Published: 2023

Journal Articles

IDH Mutations Identify a Subgroup of NPM1 Patients with a More Favorable Prognosis. a Retrospective Multicenter Study of the Filo Group

Sylvain Garciaz, Marie Anne Hospital, Colombe Saillard, MD, Yosr Hicheri, Evelyne D'Incan, Jerome Rey, Catherine Lacombe, Arnaud Pigneux, MD PhD, Marie-Christine Béné, PharmSciD, PhD, Christian Recher, MD PhD, Marie-Joelle Mozziconacci, Norbert Vey, MD

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-141229

Published: 2020

Journal Articles

Long Term Analysis of a Monocentric Cohort of Therapy-Related Acute Lymphoblastic Leukemia

Sylvain Garciaz, Amel Soua, Ilhem Rahal, Marie Anne Hospital, Colombe Saillard, MD, Yosr Hicheri, Bilal Mohty, MD, Evelyne D'Incan, Jerome Rey, MD, Norbert Vey, MD

Blood (2020) 136 (Supplement 1): 23.

https://doi.org/10.1182/blood-2020-139918

Published: 2020

Journal Articles

Pharmacokinetic-Guided Busulfan Based Myeloablative Versus Fixed Dose Reduced Intensity Conditioning Regimen in Patients Older Than 55 Years Undergoing Allogeneic Stem Cell Transplantation for High Risk Hematological Malignancies

Margaux Damge, Sabine Furst, MD, Bénédicte Devictor, Samia Harbi, MD, Joseph Ciccolini, Angela Granata, MD, Thomas Pagliardini, MD, Boris Calmels, Pharm.D., Claude Lemarie, Pharm.D., Luca Castagna, MD, Valerio Maisano, MD, Faezeh Legrand, MD, Anne-Marie Stoppa, MD, Reda Bouabdallah, Evelyne D'Incan, Norbert Vey, MD PhD, Christian Chabannon, MD PhD, Didier Blaise, MD PhD, Raynier Devillier, MD PhD

Blood (2019) 134 (Supplement_1): 4503.

https://doi.org/10.1182/blood-2019-125994

Published: 2019

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Patients of 65 Years or Older: A Monocenter Analysis on 252 Patients

Blood (2019) 134 (Supplement_1): 4625.

https://doi.org/10.1182/blood-2019-131845

Published: 2019

Journal Articles

Evaluation of a Standardized Geriatric Assessment at Diagnosis in a Prospective Cohort of Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Colombe Saillard, MD, Frederique Rousseau, Maud Cecile, Cecile Braticevic, Anne Etienne, Jerome Rey, Evelyne D'Incan, Christophe Zemmour, Norbert Vey, MD PhD, Aude Charbonnier

Blood (2018) 132 (Supplement 1): 2671.

https://doi.org/10.1182/blood-2018-99-116400

Published: 2018

Journal Articles

Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients

Norbert Vey, MD PhD, Marie Anne Hospital, Aude Collignon, Yves Collette, Daniel Birnbaum, Aude Charbonnier, Bilal Mohty, MD, Evelyne D'Incan, Jerome Rey, Remy Castellano, Camille Montersino, Max Chaffanet, Nadine Carbuccia, Jose Adelaide, Benjamin Bouchacourt, Arnaud Guille

Blood (2018) 132 (Supplement 1): 1401.

https://doi.org/10.1182/blood-2018-99-119263

Published: 2018

Journal Articles

The Odyssee Study: Prevention of Dysbiosis Complications with Autologous Fecal Microbiota Transfer (FMT) in Acute Myeloid Leukemia (AML) Patients Undergoing Intensive Treatment: Results of a Prospective Multicenter Trial

Blood (2018) 132 (Supplement 1): 1444.

https://doi.org/10.1182/blood-2018-99-112825

Published: 2018

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Improves Outcome of Patients > 60 Years with Acute Myeloid Leukemia in First Complete Remission: A 10-Year Single Center Transplantation Program Analysis

Raynier Devillier, Jerome Rey, MD, Samia Harbi, MD, Aude Charbonnier, MD, Sabine Furst, MD, Colombe Saillard, MD, Angela Granata, MD, Evelyne D'Incan, MD, Catherine Faucher, MD, Claude Lemarie, Pharm.D., Faezeh Legrand, MD, Boris Calmels, Pharm.D., Valerio Maisano, MD, Bilal Mohty, MD, Christian Chabannon, MD PhD, Pierre Jean Weiller, MDPhD, Didier Blaise, Norbert Vey

Blood (2017) 130 (Supplement 1): 3327.

https://doi.org/10.1182/blood.V130.Suppl_1.3327.3327

Published: 2017

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Patients over 60 Years with Acute Myeloid Leukemia: A Single Center Donor Comparison

Raynier Devillier, Sabine Furst, MD, Jerome Rey, MD, Angela Granata, MD, Aude Charbonnier, MD, Samia Harbi, MD, Evelyne D'Incan, MD, Thomas Pagliardini, Catherine Faucher, MD, Claude Lemarie, Pharm.D., Colombe Saillard, MD, Faezeh Legrand, MD, Boris Calmels, Pharm.D., Bilal Mohty, MD, Valerio Maisano, MD, Christian Chabannon, MD PhD, Pierre Jean Weiller, MDPhD, Norbert Vey, Didier Blaise

Blood (2017) 130 (Supplement 1): 2038.

https://doi.org/10.1182/blood.V130.Suppl_1.2038.2038

Published: 2017

Journal Articles

Topotecan Plus Cytarabine Is an Effective and Safe Regimen for Newly Diagnosed and Adverse ELN-Risk Acute Myeloid Leukemia Subset in Patients with Cardiac Comorbidities

Clemence Marcault, MD, Geoffroy Venton, Lauris Gastaud, MD, Lionel Mannone, MD, Jerome Rey, MD, Evelyne D'Incan, MD, Colombe Saillard, MD, Aude Charbonnier, MD, Sophie Raynaud, MD PhD, Norbert Vey, Thomas Cluzeau, MDPhD

Blood (2017) 130 (Supplement 1): 2615.

https://doi.org/10.1182/blood.V130.Suppl_1.2615.2615

Published: 2017

Journal Articles

Prevention of Dysbiosis Complications with Autologous Fecal Microbiota Transplantation (auto-FMT) in Acute Myeloid Leukemia (AML) Patients Undergoing Intensive Treatment (ODYSSEE study): First Results of a Prospective Multicenter Trial

Mohamad Mohty, MD PhD, Florent Malard, MDPhD, Evelyne D'Incan, MD, Xavier Thomas, MD, Christian Recher, MD PhD, Anne-Sophie Michallet, MD PhD, Pierre Peterlin, MD, Anne Vekhoff, Norbert Vey, Emilie Plantamura, Philippe Lehert, Joel Doré, Ollivier Legrand, MD PhD

Blood (2017) 130 (Supplement 1): 2624.

https://doi.org/10.1182/blood.V130.Suppl_1.2624.2624

Published: 2017

Journal Articles

Single Center Experience of Allogenic Hematopoietic Stem Cell Transplantation in 100 Patients with Myelodysplasia: The Impact of Graft-Versus-Host Disease

Colombe Saillard, Raynier Devillier, Sabine Furst, Jérome Rey, Angela Granata, Aude Charbonnier, Samia Harbi, Jean El Cheikh, Bilal Mohty, Catherine Faucher, Evelyne D'Incan, Luca Castagna, Christian Chabannon, Norbert Vey, Didier Blaise

Blood (2015) 126 (23): 5537.

https://doi.org/10.1182/blood.V126.23.5537.5537

Published: 2015

Journal Articles

Preventive Versus Curative Platelet Transfusion Strategies in the Treatment of Acute Myeloid Leukemia Patients: A Comparative Study

Aude Charbonnier, MD PhD, Michel Raba, MD, Patrick Ladaique, Laurence Augey, MD, Lilian Laborde, Jeremy Monfray, CRA, Carine Champigneulle, CRA, Mohamad Sobh, Pharm.M., Helene Labussiere-Wallet, MD, Fiorenza Barraco, MD, Sophie Ducastelle, MD, Xavier Thomas, MD PhD, Anne Etienne, MD, Thomas Prebet, MD PhD, Evelyne D'Incan, MD, Jerome Rey, MD, Franck E. Nicolini, MD PhD, Norbert Vey, MD, Mauricette Michallet, MD PhD

Blood (2014) 124 (21): 4288.

https://doi.org/10.1182/blood.V124.21.4288.4288

Published: 2014

Journal Articles

Early ICU Admission Of Newly Diagnosed Acute Myeloid Leukemia With No Organ Failure

Elodie Elkaim, Djamel Mokart, MD, PhD, Norbert Vey, MD PhD, Aude Charbonnier, MD, PhD, Evelyne D’Incan, M.D., Jerome Rey, MD, Thomas Prebet, MD, PhD, Jean-Paul Brun, MD, Antoine Sannini, MD, Muriel Picard, Christian Recher, MD PhD, Anne Etienne, MD

Blood (2013) 122 (21): 3896.

https://doi.org/10.1182/blood.V122.21.3896.3896

Published: 2013

Journal Articles

Combination of Cytarabine and Topotecan Improves Response Rate for Patients Treated for Acute Myeloid Leukemia with Persistent Disease After Frontline Induction

Thomas Prebet, MD, PhD, Estelle Jean, M.D., Aurelie Autret, B.Sc., Aude Charbonnier, Jerome Rey, MD, Anne Etienne, MD, Evelyne D'Incan, M.D., Sabine Furst, MD, Christine Arnoulet, Pharm. D., Didier Blaise, MD, Norbert Vey, MD

Blood (2011) 118 (21): 2605.

https://doi.org/10.1182/blood.V118.21.2605.2605

Published: 2011

Journal Articles

Use of RIC-Allosct In Patients Younger Than 45 Years Old Affected by MDS and Leukemia: A Monocenter Retrospective Analysis.

Roberto Crocchiolo, Jr, Luca Castagna, Sabine Furst, Jean El Cheikh, Catherine Faucher, Raynier Devilliers, Alberto Vazquez, Nawel Belmecheri, Angela Granata, Evelyne D'Incan, Norbert Vey, MD, Didier Blaise, MD

Blood (2010) 116 (21): 1316.

https://doi.org/10.1182/blood.V116.21.1316.1316

Published: 2010

Journal Articles

Outcome of Relapse After Allogeneic Stem Cell Transplantation (SCT) In Patients with acute Myeloid Leukaemia (AML).

Raynier Devillier, Roberto Crocchiolo, Jr, Anne Etienne, MD, Thomas Prebet, M.D., Ph.D., Aude Charbonnier, Sabine Furst, Jean El Cheikh, Evelyne D’Incan, Jerome Rey, Catherine Faucher, Didier Blaise, MD, Norbert Vey, MD

Blood (2010) 116 (21): 4514.

https://doi.org/10.1182/blood.V116.21.4514.4514

Published: 2010

Journal Articles

Analysis of NK Cells Receptors and NK Cells Ligands in Acute Myeloid Leukemia: Comparisons Between the Blood and the Bone Marrow.

Jerome Rey, Eloise Perrot, Caroline Veuillen, Thomas Prébet, MD, Anne Etienne, Aude Charbonnier, Evelyne D'Incan, Norbert Vey, Daniel Olive, MD, PhD

Blood (2009) 114 (22): 1643.

https://doi.org/10.1182/blood.V114.22.1643.1643

Published: 2009

NARROW

Clinical, Cytogenetic and Molecular Characterization of a 96 MDS and AML Cohort with TP53 Mutation

Poor Prognosis of SRSF2 Gene Mutations in Patients Treated with Venetoclax-Azacitidine (VEN-AZA) for Newly Diagnosed Acute Myeloid Leukemia. a Multicentric Real-Life Study of 117 Patients

IDH Mutations Identify a Subgroup of NPM1 Patients with a More Favorable Prognosis. a Retrospective Multicenter Study of the Filo Group

Long Term Analysis of a Monocentric Cohort of Therapy-Related Acute Lymphoblastic Leukemia

Pharmacokinetic-Guided Busulfan Based Myeloablative Versus Fixed Dose Reduced Intensity Conditioning Regimen in Patients Older Than 55 Years Undergoing Allogeneic Stem Cell Transplantation for High Risk Hematological Malignancies

Allogeneic Hematopoietic Stem Cell Transplantation in Patients of 65 Years or Older: A Monocenter Analysis on 252 Patients

Evaluation of a Standardized Geriatric Assessment at Diagnosis in a Prospective Cohort of Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients

The Odyssee Study: Prevention of Dysbiosis Complications with Autologous Fecal Microbiota Transfer (FMT) in Acute Myeloid Leukemia (AML) Patients Undergoing Intensive Treatment: Results of a Prospective Multicenter Trial

Allogeneic Hematopoietic Stem Cell Transplantation Improves Outcome of Patients > 60 Years with Acute Myeloid Leukemia in First Complete Remission: A 10-Year Single Center Transplantation Program Analysis

Allogeneic Hematopoietic Stem Cell Transplantation for Patients over 60 Years with Acute Myeloid Leukemia: A Single Center Donor Comparison

Topotecan Plus Cytarabine Is an Effective and Safe Regimen for Newly Diagnosed and Adverse ELN-Risk Acute Myeloid Leukemia Subset in Patients with Cardiac Comorbidities

Prevention of Dysbiosis Complications with Autologous Fecal Microbiota Transplantation (auto-FMT) in Acute Myeloid Leukemia (AML) Patients Undergoing Intensive Treatment (ODYSSEE study): First Results of a Prospective Multicenter Trial

Single Center Experience of Allogenic Hematopoietic Stem Cell Transplantation in 100 Patients with Myelodysplasia: The Impact of Graft-Versus-Host Disease

Preventive Versus Curative Platelet Transfusion Strategies in the Treatment of Acute Myeloid Leukemia Patients: A Comparative Study

Early ICU Admission Of Newly Diagnosed Acute Myeloid Leukemia With No Organ Failure

Combination of Cytarabine and Topotecan Improves Response Rate for Patients Treated for Acute Myeloid Leukemia with Persistent Disease After Frontline Induction

Use of RIC-Allosct In Patients Younger Than 45 Years Old Affected by MDS and Leukemia: A Monocenter Retrospective Analysis.

Outcome of Relapse After Allogeneic Stem Cell Transplantation (SCT) In Patients with acute Myeloid Leukaemia (AML).

Analysis of NK Cells Receptors and NK Cells Ligands in Acute Myeloid Leukemia: Comparisons Between the Blood and the Bone Marrow.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only